Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris A Hadaschik

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
European Urology|June 24, 2025
Reply to Zhengbo Pan, Run Shi, and Zhaokai Zhou's Letter to the Editor - Re: Madeleine J. Karpinski, Kambiz Rahbar, Martin Bögemann, et al. Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.04.017Madeleine J Karpinski, Boris A Hadaschik, Wolfgang P Fendler
European Urology|October 20, 2024
Prostate-specific Membrane Antigen (PSMA) Spatial Biomarker: Standardized Positron Emission Tomography Disease Maps Provide Accurate Prediction of Overall Survival in Prostate CancerWolfgang P Fendler, Viktor Grünwald, Ken Herrmann, et al.
Future Oncology (London, England)|October 23, 2013
How could imaging reduce therapy-associated morbidity in rhabdomyosarcoma of the bladder or prostate?Timur H Kuru, Matthias Roethke, Michael Fenchel, et al.
Translational Andrology and Urology|January 28, 2016
The current and future role of magnetic resonance imaging in prostate cancer detection and managementJan Philipp Radtke, Dogu Teber, Markus Hohenfellner, et al.
Current Opinion in Urology|April 24, 2025
Prostate-specific membrane antigen positron-emission tomography for novel risk-stratification of biochemical recurrenceMadeleine J Karpinski, Claudia Kesch, Boris A Hadaschik, et al.
The Lancet. Oncology|October 31, 2024
PSMA-PET research: addressing challenges and prospects - Authors' replyBoris A Hadaschik, Madeleine J Karpinski, Johannes Hüsing, et al.
Archivos Espanoles De Urologia|December 6, 2017
Multiparametric-MRI-Guided Biopsy in the Era of Precision MedicineMiguel A Bergero, Pablo F Martínez, Jan P Radtke, et al.
Urologia Internationalis|July 11, 2013
Improving accuracy in image-guided prostate biopsy by using trocar-sharpened needlesTimur H Kuru, Tobias Simpfendörfer, Matthias Roethke, et al.
Translational Andrology and Urology|July 10, 2024
The current role of pentafecta in the reporting of radical cystectomy outcomes: a scoping reviewOsama Mahmoud, Mulham Al-Nader, Lukas Püllen, et al.
Urologic Oncology|March 6, 2012
Two decades' experience with a prospective biobank for urologic oncology: research, clinical care, and the patients' viewJohannes Huber, Esther Herpel, Hildegard Jakobi, et al.
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
European Urology|June 24, 2025
Reply to Zhengbo Pan, Run Shi, and Zhaokai Zhou's Letter to the Editor - Re: Madeleine J. Karpinski, Kambiz Rahbar, Martin Bögemann, et al. Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.04.017Madeleine J Karpinski, Boris A Hadaschik, Wolfgang P Fendler
European Urology|October 20, 2024
Prostate-specific Membrane Antigen (PSMA) Spatial Biomarker: Standardized Positron Emission Tomography Disease Maps Provide Accurate Prediction of Overall Survival in Prostate CancerWolfgang P Fendler, Viktor Grünwald, Ken Herrmann, et al.
Future Oncology (London, England)|October 23, 2013
How could imaging reduce therapy-associated morbidity in rhabdomyosarcoma of the bladder or prostate?Timur H Kuru, Matthias Roethke, Michael Fenchel, et al.
Translational Andrology and Urology|January 28, 2016
The current and future role of magnetic resonance imaging in prostate cancer detection and managementJan Philipp Radtke, Dogu Teber, Markus Hohenfellner, et al.
Current Opinion in Urology|April 24, 2025
Prostate-specific membrane antigen positron-emission tomography for novel risk-stratification of biochemical recurrenceMadeleine J Karpinski, Claudia Kesch, Boris A Hadaschik, et al.
The Lancet. Oncology|October 31, 2024
PSMA-PET research: addressing challenges and prospects - Authors' replyBoris A Hadaschik, Madeleine J Karpinski, Johannes Hüsing, et al.
Archivos Espanoles De Urologia|December 6, 2017
Multiparametric-MRI-Guided Biopsy in the Era of Precision MedicineMiguel A Bergero, Pablo F Martínez, Jan P Radtke, et al.
Urologia Internationalis|July 11, 2013
Improving accuracy in image-guided prostate biopsy by using trocar-sharpened needlesTimur H Kuru, Tobias Simpfendörfer, Matthias Roethke, et al.
Translational Andrology and Urology|July 10, 2024
The current role of pentafecta in the reporting of radical cystectomy outcomes: a scoping reviewOsama Mahmoud, Mulham Al-Nader, Lukas Püllen, et al.
Urologic Oncology|March 6, 2012
Two decades' experience with a prospective biobank for urologic oncology: research, clinical care, and the patients' viewJohannes Huber, Esther Herpel, Hildegard Jakobi, et al.
Pageof 13